Stuart  Seropian, MD

Stuart Seropian, MD

Yale Cancer Center/Smilow Cancer Hospital

Professor of Internal Medicine (Hematology); Acting Director, Stem Cell Transplantation; Chairman, Car-T Cell Joint Steering Committee; Director, Unrelated Donor Transplant Program, Stem Cell Transplantation; Co-Director, Immune Effector Cell Therapy; Co-Director, Adult CAR T-Cell Therapy Program

Expertise:

Dr. Seropian is a Professor of Medicine in the department of Internal Medicine, Section of Hematology, Yale University School of Medicine. He received his medical degree from George Washington University School of Medicine and completed residency and fellowship training at Yale-New Haven Hospital/Yale University School of Medicine in 1996.
Dr. Seropian serves as Interim Director of the Stem Cell Transplant Program, Co-Director, Immune Effector Cell Therapy, and Chairman, Car-T Cell Joint Steering Committee, Yale-New Haven Hospital. Dr. Seropian’s research interests include methods to improve the outcomes of transplantation through use of novel anti-cancer agents and new methods of treating graft versus host disease

Education & Training:
Resident- Yale-New Haven Hospital (1994)
Intern- Yale-New Haven Hospital (1992)
MD- George Washington University (1991)
BS- Tufts University (1984)

Honors & Recognition:

2016 Yale Cancer Center Award for Clinical Excellence
2014 David S. Fischer Annual Award for Outstanding Teaching and Mentoring of Fellows in Hematology at Yale Cancer Center	
1991 Alpha Omega Alpha Medical Honor Society	AOA
1991 MD with Distinction at George Washington University School of Medicine
1989 Horowitz Award, NBME Part I at George Washington University School of Medicine	

No Clipping

No Research/Citations

Yale Cancer Center Earns International Reaccreditation for Expertise in CAR T-cell Therapy and Stem Cell Transplantation

Yale Cancer Center (YCC) and Smilow Cancer Hospital (SCH) have again received an internationally recognized accreditation for cellular therapy and stem cell transplantation from the Foundation for the Accreditation of Cellular Therapy (FACT), giving patients life-saving cancer treatment options in Connecticut.
07-May-2024 04:05:40 PM EDT

No Quotes

Available for logged-in users onlyLogin HereorRegister

No Video

close
0.07969